Skip to main content
. 2023 Dec 13;12(4):451–458. doi: 10.1002/ueg2.12497

FIGURE 1.

FIGURE 1

The percentage of patients reaching transmural remission according to different ratios of treatment escalation per abnormal fecal calprotectin (a) and considering a cutoff ≥50% versus <50% (b).